Brown, Lisle/Cummings’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.38K Hold
300
﹤0.01% 643
2026
Q1
$7.18K Hold
300
﹤0.01% 624
2025
Q4
$6.79K Hold
300
﹤0.01% 531
2025
Q3
$6.04K Hold
300
﹤0.01% 551
2025
Q2
$4.28K Hold
300
﹤0.01% 581
2025
Q1
$3.15K Hold
300
﹤0.01% 607
2024
Q4
$3.63K Hold
300
﹤0.01% 561
2024
Q3
$4.41K Hold
300
﹤0.01% 524
2024
Q2
$4.33K Hold
300
﹤0.01% 514
2024
Q1
$4.88K Hold
300
﹤0.01% 486
2023
Q4
$4.47K Hold
300
﹤0.01% 497
2023
Q3
$3.37K Hold
300
﹤0.01% 487
2023
Q2
$3.02K Hold
300
﹤0.01% 504
2023
Q1
$2.82K Hold
300
﹤0.01% 481
2022
Q4
$3.67K Hold
300
﹤0.01% 454
2022
Q3
$3.72K Hold
300
﹤0.01% 446
2022
Q2
$5.89K Hold
300
﹤0.01% 407
2022
Q1
$7.83K Hold
300
﹤0.01% 408
2021
Q4
$8.51K Buy
+300
New +$9.33K ﹤0.01% 386

Other funds holding ELAN

Brown, Lisle/Cummings's ELAN Position: Q2 2026 in Review

Brown, Lisle/Cummings held its Elanco Animal Health (ELAN) position steady in Q2 2026 at 300 shares worth $7.38K. The position accounts for ﹤0.01% of the portfolio, ranked #643.

Brown, Lisle/Cummings first reported a position in ELAN in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.51K in Q4 2021. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Brown, Lisle/Cummings held 300 shares of Elanco Animal Health worth $7.38K as of Q2 2026.
  • Brown, Lisle/Cummings left its Elanco Animal Health share count unchanged in Q2 2026.
  • Elanco Animal Health made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #643 holding.
  • Brown, Lisle/Cummings first reported a position in Elanco Animal Health in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Elanco Animal Health position peaked at $8.51K in Q4 2021.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.